Dr. Julia Song, MD

Dr. Song practices at Coast Urological Medical Group in Los Alamitos, California.

Dr. Song's NPI, 1982629010, was assigned on July 12, 2006. Dr. Song graduated from Feinberg School of Medicine in 1998. Dr. Song holds California license A87753.

Dr. Song's primary practice is Coast Urological Medical Group, at 3771 Katella Ave, Los Alamitos, CA 90720 in Orange County. The practice phone is (562) 430-0581.

Dr. Song's primary practice is Coast Urological Medical Group in Los Alamitos, California. Dmand AI also links Dr. Song to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Song is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Song's licenses on file in 4 states: California, North Carolina, Florida and Illinois.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Song treats.

CMS data shows 2,191 Medicare services from Dr. Song across 21 procedure codes in 2024, for 445 Medicare patients. Medicare paid $186,206 for them.

CMS counts 445 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 74, with 63% women.

In 2024, Dr. Song wrote 3,849 Medicare Part D claims for 557 patients. 50% of them were for generic drugs. CMS names the drug for 3,571 of them, across 40 drugs with 11 or more claims each, at $1,616,304 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Song for performance year 2024, reported individually. Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of cataract surgery by Dr. Song, more than 59% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Song, published from 2013 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Intraocular Pressure, Ciliary Body and Glaucoma Drainage Implants. Dr. Song has published most often in J Med Case Rep. Dr. Song's most frequent co-authors are Alice Song, MD, Robert Wayne Bowman, MD and Alessandro Attilio Castellarin, MD.

CMS Open Payments shows 203 general payments to Dr. Song from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $948.

Dmand AI lists 1 award for Dr. Song, most recently CMS Stage 1 EHR in 2013.

Dr. Song graduated from Feinberg School of Medicine in 1998. Dr. Song is a member of AAO and American Glaucoma Society.

Dr. Song is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.